The finding may open a whole new world in the study of Alzheimer's disease, said biophysicist Aneta Stefanovska.

Findings indicate rising microplastic concentrations in human brains and organs, urging deeper investigation into their ...

Orchard Therapeutics, a Kyowa Kirin company, today announced presentations from seven abstracts from across its hematopoietic stem cell (HSC) gene therapy portfolio will be featured at the 21st Annual ...

Another film getting reissued in 2025 is Picnic at Hanging Rock. The 1975 mystery centres around several schoolgirls and ...

Zevra to receive a 2025 New Treatment Award for MIPLYFFA™ at the 21st Annual WORLDSymposiumEight abstracts discussing data and clinical ...

Spasmodic dysphonia is a rare neurological disorder that causes a strained voice. RFK Jr. says he has had the disorder for ...

ioTracker Cells, the new range within bit.bio's ioCells portfolio, deliver added visualisation capabilities that enhance the portfolio of deterministically-programmed human iPSC-derived cells powered ...

An estimated 3.4 billion people—43% of the world population—had a condition affecting the nervous system in 2021, leading to ...

HighlightsTopline data for ATH434-201 randomized, double-blind Phase 2 clinical trial on track for expected release by early February ...

Applications are soon closing for the next cohort of Nevada ENDURE, a two-year program for undergraduate students interested in pursuing a Ph.D. in neuroscience or a related field. Nevada ENDURE, ...

STOCKHOLM, SE / ACCESSWIRE / January 21, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops candidate drugs for diseases af ...